Clinical trial
Assessment of Improvement in Glycemic Control, Weight, and Insulin Sensitivity in Obese Patients After Fecal Microbiota Transplantation (FMT) Against the Background of Glucose-lowering Therapy
NCT04579263 is registered in ClinicalTrials.gov with Federal Research and Clinical Center of Physical-Chemical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Improvement in Glycemic Control, Weight, and Insulin Sensitivity in Obese Patients After Fecal Microbiota Transplantation (FMT) Against the Background of Glucose-lowering Therapy
- Lead sponsor
- Federal Research and Clinical Center of Physical-Chemical Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 15, 2020
- Completion date
- September 22, 2020
- Enrollment
- 2 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
obesity; familial